C1 Fund INC Form 4 insider transactions

Insider transactions: buys and sells by directors, officers and ten percent owners, filed within two business days of the trade.

NYSE
Najamul Hasan Kidwai, Director and CEO of C1 Fund Inc., acquired 5,000 shares of common stock.
NYSE
C1 Fund Inc. Director Scott Reed reported transactions involving the acquisition of common stock, increasing his beneficial ownership.
NYSE
Director Scott Reed purchased 15,000 shares of C1 Fund Inc. common stock across two transactions in June 2026.
NYSE
C1 Fund Inc. Director Jeffrey H. Singer reported the purchase of 2,000 shares of common stock at $4.89 per share.
NYSE
C1 Fund Inc.'s Chief Investment Officer, Elliot Han, acquired 5,000 shares of common stock at $4.81 per share in a pre-planned transaction.
NYSE
C1 Fund Inc.'s CEO and Director, Najamul Hasan Kidwai, purchased 12,030 shares of common stock at $4.93 per share.
NYSE
C1 Fund Inc. Director Scott A. Reed acquired additional common stock through direct and indirect purchases in December 2025.
NYSE
C1 Fund Inc. Director Scott A. Reed acquired additional common stock totaling $65,100 across two transactions, increasing his beneficial ownership.
NYSE
C1 Fund Inc.'s CEO and Director, Najamul Hasan Kidwai, purchased 9,100 shares of common stock at $5.40 per share.
NYSE
C1 Fund Inc. CEO Najamul Hasan Kidwai purchased 9,000 shares of common stock at $5.33 per share, signaling confidence in the company's future.
NYSE
C1 Fund Inc. Director Matthew Krna purchased 1,693 shares of common stock at $5.91 per share, increasing his direct beneficial ownership.
NYSE
C1 Fund Inc. Director Scott A. Reed acquired 6,500 shares of common stock at $5.31 per share.
NYSE
C1 Fund Inc. Director Scott A. Reed increased his beneficial ownership by acquiring 13,500 shares of common stock.
NYSE
C1 Fund Inc. Director Scott A. Reed has filed a Form 4 detailing planned acquisitions of 60,000 shares of common stock in August 2025.
NYSE
C1 Fund Inc. CEO Najamul Hasan Kidwai's indirect beneficial ownership adjusted following the cancellation of 100,000 shares due to unexercised IPO over-allotment option.
NYSE
C1 Fund Inc. Director Michael Xu Zhao reported an indirect disposition of shares due to the non-exercise of an over-allotment option by underwriters.
NYSE
C1 Fund Inc. Director Michael Lempres reports a change in beneficial ownership following the cancellation of shares due to an unexercised over-allotment option.
NYSE
C1 Fund Inc.'s Chief Financial Officer, David Hytha, reported an adjustment to his indirect beneficial ownership of common stock following the non-exercise of an over-allotment option by underwriters.
NYSE
C1 Group LLC's beneficial ownership in C1 Fund Inc. decreased by 100,000 shares due to the non-exercise of an over-allotment option by underwriters.
NYSE
C1 Fund Inc.'s Chief Financial Officer, David Hytha, directly acquired 5,004 shares of common stock at $10 per share, increasing his direct beneficial ownership.
NYSE
C1 Fund Inc. Director Sara Wardell-Smith reported a planned acquisition of 30,000 shares of common stock for $300,000, effective August 8, 2025.